Bleeding and thromboembolic risks of internal cardioversion for persistent atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 12, 2002, Pages 1752-1755

  Tse, Hung Fat ^a   Lau, Chu Pak ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bleeding; Internal cardioversion; Thromboembolism

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVERSION; CONSERVATIVE TREATMENT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMATOMA; HEPARINIZATION; HUMAN; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; R WAVE; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

EID: 0036918871     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01752.x     Document Type: Article

References (12)

1. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29:469-489.
2. DeSilva RA, Grayboys TTS, Podrod PJ, et al. Cardioversion and defibrillation. Am Heart J 1980; 100:881-895.
3. Murgatroyd FD, Slade AKB, Sopher SM, et al. Efficacy and tolerability of low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995; 25:1347-1353.
4. Schmitt C, Alt E, Plewan A, et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996; 28:994-999.
5. Lok NS, Lau CP, Ho DSW, et al. Hemodynamic effects and clinical determinants of defibrillation threshold for low energy transvenous atrial defibrillation in patients with chronic atrial fibrillation. PACE 1997; 20:899-908.
6. Levy S, Richard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 27:750-755.
7. Levy S, Richard P, Gueunoun M, et al. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long term results. Circulation 1997; 96:253-259.
8. Lok NS, Lau CP, Tse HF, et al. Clinical shock tolerability and comparison of different atrial electrode locations on the efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997; 30:1324-1330.
9. Tracy CM, Akhtar M, DiMarco JP, et al. American college of Cardiology/American Heart Association clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion: A report of the American College of Cardiology/American Heart Association/American college of physicians-american society of internal medicine task force on clinical competence. Circulation 2000; 102:2309-2320.
10. Simons GR, Newby KH, Kearney MM, et al. A. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with history of ventricular tachycardia: Effects of rate and repolarization time on proarrhythmic risk. PACE 1998; 21:430-437.
11. Tse HF, Lau CP. Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function. Am J Cardiol 1999; 84:1090-1092.
12. Schmieder S, Schneider MA, Karch MR, et al. Internal low energy cardioversion of atrial fibrillation using a single lead system: Comparison of a left and right pulmonary artery catheter approach. PACE 2001; 24:1108-1112.